Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2014-05-14

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1136/jnnp-2013-307343PMID 24828898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records

  2013cited by this paper
• Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.

  2012cited by this paper
• Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY

  2011cited by this paper
• Study Protocol of Registry – version 3.0 – European Huntington’s Disease Network (EHDN)

  2011cited by this paper
• Ethics approval This study was conducted with the approval of the East London and City Health Authority Ethic Committee. Provenance and peer review Not commissioned; externally peer reviewed.

  2011cited by this paper
• Discriminant analysis of Beck Depression Inventory and Hamilton Rating Scale for Depression in Huntington's disease.

  2011cited by this paper
• Factor analysis of behavioural symptoms in Huntington’s disease

  2010cited by this paper
• Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY.

  2010cited by this paper
• Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

  2010cited by this paper
• Long-term outcome of presymptomatic testing in Huntington disease

  2009cited by this paper
• Beyond the brain: widespread pathology in Huntington's disease.

  2009cited by this paper
• Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives.

  2008cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2008cited by this paper
• Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.

  2007cited by this paper
• Huntington's disease.

  2007cited by this paper
• Psychopathology in verified Huntington's disease gene carriers.

  2007cited by this paper
• Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.

  2007cited by this paper
• Psychiatric disorders in preclinical Huntington’s disease

  2006cited by this paper
• Depression and stages of Huntington's disease.

  2005cited by this paper
• Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects

  2002cited by this paper
• Behavioral changes in Huntington Disease.

  2001cited by this paper
• Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders

  2001cited by this paper
• Neuropsychiatric aspects of Huntington's disease

  2001cited by this paper
• A clinical study of patients with genetically confirmed Huntington's disease from India.

  2001cited by this paper
• Unified Huntington's disease rating scale: Reliability and consistency

  1996cited by this paper
• Unified Huntington's disease rating scale: reliability and consistency

  1996cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Huntington's disease

  1984cited by this paper
• Huntington disease

  1979cited by this paper

• Prebiotics improve motor function, cognition and gut health in a preclinical model of Huntington's disease.

  2025cites this paper
• Mapping Longitudinal Psychiatric Signatures in Huntington's Disease.

  2025cites this paper
• Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD).

  2025cites this paper
• Psychiatric‐onset neuronal intranuclear inclusion disease in a psychiatry‐based dementia‐enriched cohort in Japan

  2025cites this paper
• Amelioration of transcriptional disturbances in female BACHD rats by environmental enrichment.

  2025cites this paper
• A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington’s disease

  2025cites this paper
• Psychosis preceding Motor Symptoms in Huntington’s Disease: A Psychiatric Inpatient Case Series

  2025cites this paper
• ‘It’s more than just irritability’: perspectives and experiences of irritability among people affected by Huntington’s disease

  2025cites this paper
• Antidepressants and Slower Disease Progression in Huntington's Disease

  2025cites this paper
• Striato-cortical connectivity patterns predict clinical profiles in Huntington’s disease

  2025cites this paper
• Specific contribution of cognitive and motor impairments with functional capacity and dependence in Huntington’s disease

  2025cites this paper
• The Role of MicroRNAs in Neurodegeneration: Insights from Huntington’s Disease

  2025cites this paper
• TDP-43 overexpression in the hypothalamus drives neuropathology, dysregulates metabolism and impairs behavior in mice

  2025cites this paper
• Update on Genetic Chorea

  2025cites this paper
• Acceptance and commitment therapy with Huntington's disease: A narrative review and case report of a caregiver-assisted intervention

  2025cites this paper
• Update on the Symptomatic Treatment of Huntington’s Disease: From Pathophysiology to Clinical Practice

  2025cites this paper
• Emotional speech markers of psychiatric disturbance in Huntington’s disease

  2025cites this paper
• Pharmacological Treatment of Neuropsychiatric Symptoms in Huntington's Disease: A Systematic Review

  2025cites this paper
• Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review

  2025cites this paper
• Goal-directedness deficit in Huntington’s disease

  2025cites this paper
• Psychosis in Huntington's disease: a review and comparison with schizophrenia.

  2025cites this paper
• Decision context and neurobehavioural disturbance in Huntington’s disease

  2025cites this paper
• Excessive emotional reactivity in a case of behavioral variant frontotemporal dementia with amyotrophic lateral sclerosis

  2025cites this paper
• Early Psychotic Symptoms as Indicators of Huntington’s Disease Onset

  2025cites this paper
• Pathomechanisms of behavioral abnormalities in Huntington disease: an update

  2024cites this paper
• Insights into RNA‐mediated pathology in new mouse models of Huntington's disease

  2024cites this paper
• Huntingtin CAG repeat size variations below the Huntington’s disease threshold: associations with depression, anxiety and basal ganglia structure

  2024cites this paper
• Treatment of Depression in Huntington's Disease: A Systematic Review.

  2024cites this paper
• Huntingtin CAG repeat size variations outside the Huntington’s disease complex: associations with depression and anxiety phenotypes and basal ganglia structure

  2024cites this paper
• Sex differences in sleep architecture in a mouse model of Huntington’s disease

  2024cites this paper
• Clinical Review of Juvenile Huntington’s Disease

  2024cites this paper
• Is maintenance therapy warranted for recurrent mania in a woman with a positive family history of Huntington's disease?

  2024cites this paper
• The characteristic and prognostic role of blood inflammatory markers in patients with Huntington’s disease from China

  2024cites this paper
• Intrathecal baclofen pump for severe hypertonia in a patient with juvenile Huntington’s disease: illustrative case

  2024cites this paper
• Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders: A Review.

  2024cites this paper
• Frequency of depression in Huntington's disease: A systematic review and meta-analysis

  2024cites this paper
• Deciphering the Neuropsychiatric Landscape of Huntington’s Disease: Insights and Implications—A Case Report

  2024cites this paper
• Psychiatrische Symptome der Huntington-Krankheit

  2024influential citation
• Sex-Specific Differences in the Progression of Huntington’s Disease Symptoms – A National Study in China

  2024cites this paper
• A Practical Guide for Clinical Approach to Patients With Huntington’s Disease in Korea

  2024cites this paper
• Translational Approach Using Advanced Therapy Medicinal Products for Huntington's Disease.

  2024cites this paper
• “I Wouldn’t Even Know What to Ask for”: Patients’ and Caregivers’ Experiences of Psychological Support for Huntington’s Disease in Italy

  2024cites this paper
• Advancements in surgical treatments for Huntington disease: From pallidotomy to experimental therapies

  2024cites this paper
• The pathobiology of depression in Huntington’s disease: an unresolved puzzle

  2024cites this paper
• Sleep fragmentation despite intact rest-activity patterns in premanifest Huntington's disease: An actigraphy study.

  2024cites this paper
• Medication Use and Treatment Indications in Huntington's Disease; Analyses from a Large Cohort

  2024cites this paper
• Huntington’s Disease in Chile: Epidemiological and Genetic Aspects

  2023cites this paper
• Sex Differences in Sleep Phenotypes in the BACHD Mouse Model of Huntington’s Disease

  2023cites this paper
• Koro-like syndrome in Huntington's disease.

  2023cites this paper
• Cognitive Impairment in Neurodegenerative Movement Disorders

  2023cites this paper
• Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review

  2023cites this paper
• Cholinergic deficits selectively boost cortical intratelencephalic control of striatum in male Huntington’s disease model mice

  2023cites this paper
• What we don't need to prove but need to do in multidisciplinary treatment and care in Huntington's disease: a position paper

  2023cites this paper
• Pain in Huntington’s disease and its potential mechanisms

  2023cites this paper
• A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington's disease.

  2023cites this paper
• Mental health symptoms among those affected by Huntington's disease: A cross‐sectional study

  2023cites this paper
• Huntington Study Group's Neuropsychology Working Group: Implementing Non‐Motor Diagnostic Criteria

  2023cites this paper
• Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)

  2023cites this paper
• Obsessive-Compulsive and Perseverative Behaviors in Huntington's Disease.

  2023cites this paper
• Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases

  2023cites this paper
• Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders.

  2023cites this paper
• Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments

  2023cites this paper
• Neurophysiological correlates of non-motor symptoms in late premanifest and early-stage manifest huntington's disease.

  2023cites this paper
• Hippocampal morphology in Huntington's disease, implications for plasticity and pathogenesis: The IMAGE-HD study.

  2023cites this paper
• Dietary fibre confers therapeutic effects in a preclinical model of Huntington's disease.

  2023cites this paper
• Clinical Correlates of Depression and Suicidality in Huntington Disease: An Analysis of the Enroll-HD Observational Study

  2022cites this paper
• Current and Possible Future Therapeutic Options for Huntington’s Disease

  2022cites this paper
• Benefit of cognitive behavioral therapy for post-traumatic stress disorder and obsessive-compulsive disorders in Huntington’s disease: a case report

  2022cites this paper
• A qualitative examination of apathy and physical activity in Huntington's and Parkinson's disease.

  2022cites this paper
• Anhedonia in Neurodegenerative Diseases.

  2022cites this paper
• Association between sex and Huntington’s disease: an updated review on symptomatology and prognosis of neurodegenerative disorders

  2022cites this paper
• Negative symptoms in Huntington’s disease

  2022cites this paper
• Environmental stimulation in Huntington disease patients and animal models.

  2022cites this paper
• Different depression: motivational anhedonia governs antidepressant efficacy in Huntington’s disease

  2022cites this paper
• Sexual Dimorphism in Neurodegenerative Diseases and in Brain Ischemia

  2022cites this paper
• Intertwining Neuropathogenic Impacts of Aberrant Circadian Rhythm and Impaired Neuroregenerative Plasticity in Huntington’s Disease: Neurotherapeutic Significance of Chemogenetics

  2022cites this paper
• Psychotropic medication use in Huntington's disease: A retrospective cohort study.

  2022cites this paper
• Frequency and Pathophysiology of Apathy in Huntington Disease: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients.

  2022cites this paper
• Excessive response to provocation rather than disinhibition mediates irritable behaviour in Huntington’s disease

  2022cites this paper
• Inflammasome activation and assembly in Huntington's disease.

  2022cites this paper
• A computational theory of evaluation processes in apathy

  2022cites this paper
• Apathy and Depression in Huntington's Disease: Distinct Longitudinal Trajectories and Clinical Correlates.

  2022cites this paper
• The effects of antidepressants on depressive symptoms in manifest Huntington's disease.

  2022cites this paper
• Psychological discomfort in carriers and non-carriers of the Huntington disease mutation and its relationship with disease burden.

  2022cites this paper
• Reproductive choices and intrafamilial communication in neurogenetic diseases with different self-estimated severities

  2022cites this paper
• Huntington’s disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing exploration

  2022cites this paper
• Investigating resting state neurophysiological markers of apathy and processing speed in prodromal and early-stage manifest Huntington's disease

  2022influential citation
• Malestar psicológico en portadores y no portadores de la mutación causante de enfermedad de Huntington y su relación con la carga de la enfermedad

  2022cites this paper
• The Comprehensive Analysis of Motor and Neuropsychiatric Symptoms in Patients with Huntington’s Disease from China: A Cross-Sectional Study

  2022cites this paper
• More than Just a Brain Disorder: A Five-Point Manifesto for Psychological Care for People with Huntington’s Disease

  2022cites this paper
• Sex and gender differences in movement disorders: Parkinson's disease, essential tremor, dystonia and chorea.

  2022cites this paper
• Using a Clinical Formulation to Understand Psychological Distress in People Affected by Huntington’s Disease: A Descriptive, Evidence-Based Model

  2022cites this paper
• Primary Palliative Care in Huntington's Disease

  2022cites this paper
• Revisiting cell and gene therapies in Huntington’s disease

  2021cites this paper
• Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis

  2021cites this paper
• Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease

  2021cites this paper
• Aberrant Striatal Value Representation in Huntington's Disease Gene Carriers 25 Years Before Onset

  2021cites this paper
• Benefit of long-acting paliperidone in Huntington's disease: a case report.

  2021cites this paper
• Cholinergic de cits selectively boost cortical intratelencephalic control of the striatum in Huntington’s disease

  2021cites this paper